Poddighe P J, Moesker O, Smeets D, Awwad B H, Ramaekers F C, Hopman A H
Department of Pathology, University Hospital Nijmegen, The Netherlands.
Cancer Res. 1991 Apr 1;51(7):1959-67.
Numerical chromosome aberrations were detected in hematological cancers by nonradioactive in situ hybridization (ISH) procedures, using centromere specific probes for chromosomes 1, 7, 8, 9, 10, 11, 16, 17, 18, X, and Y. All 15 cases could be evaluated by ISH for these 11 probes. Our experiments show that in seven of these randomly selected leukemia bone marrow cell suspensions numerical aberrations for one or two chromosomes could be detected by this method. The results of ISH on interphase nuclei and in some cases on metaphase preparations were compared with karyotyping data. Seven cases of chromosomal aberrations observed with ISH (three for monosomy and four for trisomy) were confirmed by this classical cytogenetic technique, whereas in five instances an aberration was found only with ISH (twice for monosomy, twice for trisomy, and one disomy for the Y-probe). One case of a trisomy for chromosome 1 observed by ISH on interphase nuclei could be explained by a marker chromosome, a finding that was further substantiated by ISH on metaphase spreads. In this case double-target ISH on interphase cells with the probes for chromosomes 1 and 16 strongly suggested a translocation between these chromosomes. Also, in one case a marker chromosome could be characterized as a translocation between chromosomes 7 and 17. In this latter case the cytogenetic examinations revealed only monosomy for chromosomes 7 and 17 in addition to noncharacterized marker chromosomes. Our results indicate that the nonradioactive ISH procedure in combination with chromosome specific repetitive centromeric probes is a powerful tool for studying both numerical and structural chromosomal aberrations in interphase nuclei of leukemias. It may therefore become a valuable and routine diagnostic tool in addition to the existing karyotyping procedures.
通过非放射性原位杂交(ISH)程序,使用针对染色体1、7、8、9、10、11、16、17、18、X和Y的着丝粒特异性探针,在血液系统癌症中检测到染色体数目异常。对于这11种探针,所有15例病例均可通过ISH进行评估。我们的实验表明,在这些随机选择的白血病骨髓细胞悬液中,有7例可以通过该方法检测到一两条染色体的数目异常。将ISH在间期核以及某些情况下在中期制备物上的结果与核型分析数据进行了比较。ISH观察到的7例染色体异常(3例单体型和4例三体型)通过这种经典细胞遗传学技术得到了证实,而在5例中,仅ISH发现了异常(2例单体型、2例三体型和1例Y探针双体型)。ISH在间期核上观察到的1例染色体1三体可以用一条标记染色体来解释,中期铺展的ISH进一步证实了这一发现。在这种情况下,用染色体1和16的探针在间期细胞上进行双靶点ISH强烈提示这两条染色体之间存在易位。此外,在1例中,一条标记染色体可被鉴定为染色体7和17之间的易位。在后一种情况下,细胞遗传学检查除了未鉴定的标记染色体外,仅发现染色体7和17单体型。我们的结果表明,非放射性ISH程序与染色体特异性重复着丝粒探针相结合是研究白血病间期核中染色体数目和结构异常的有力工具。因此,除了现有的核型分析程序外,它可能成为一种有价值的常规诊断工具。